US WorldMeds
Manufacturing · Kentucky, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
4441 Springdale Rd, Louisville, Kentucky...Phone Number
(866) 750-8796Website
www.usworldmeds.comRevenue
$44.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
1
1
1
1
1
About US WorldMeds
US WorldMeds is a specialty pharmaceutical company dedicated to developing, licensing and commercializing unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products. Through sound science and targeted commercialization, the Kentucky-based company continually strives to identify specialty and orphan products for diseases with limited patient populations.Explore more
US WorldMeds Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is US WorldMeds your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when US WorldMeds launches new products
Congratulate Masked Content for being promoted to Masked Content at US WorldMeds
US WorldMeds, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on US WorldMeds recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if US WorldMeds is spiking on competitors!
Check if US WorldMeds has recently received funding, and reach out quickly before it becomes old news!
Click to see if US WorldMeds had a recent Job posting/layoffs
Funding: Get notified immidiatlly once US WorldMeds has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to US WorldMeds
Compare insights from companies similar to US WorldMeds, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Compare CEO
How does Breck Jones compare against Competing Companies' CEOs?
PJ
Breck Jones
Chief Executive Officer at US WorldMeds
Bottom 35%
CEO management styleGood
0%Bad
100%VS.
Top 10%
CEO effectiveness to drive business results
Excellent
25%
Good
0%
Average
50%
Poor
12%
Very Bad
12%
Good
75%Bad
25%Joaquin Duato
CEO at Johnson & Johnson Servi...
Vasant Narasimha...
CEO at Novartis
Company Profile Activity
Activity Insights
US WorldMeds is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
US WorldMeds is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about US WorldMeds.
US WorldMeds financials insights
Gather financial insights about US WorldMeds, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$5M
US WorldMeds Tech Stack
A closer look at the technologies used by US WorldMeds
Most Recent Scoops
Person-Based
Pharmaceuticals
Open Position
Hiring Plans
US WorldMeds has more open roles in Medical & Health than it has had at any time in the past 12 months. Areas of expertise include: Clinical Trial Management Systems, and Clinical System Operations.
Hiring Plans
Open Position
Open Position
US WorldMeds News & Media
US WorldMeds Completes Acquisition of Adaptimmune's Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel
LOUISVILLE, Ky., Aug. 4, 2025 /PRNewswire/ -- US WorldMeds (USWM) reported the successful closing of the previously announced acquisition of Adaptimmune Therapeutics plc's (Adaptimmune) cell–therapy assets—including TECELRA® (afamitresgene autoleucel), lete–cel, afami–cel, and uza–cel....FDA Approves Iwilfin (eflornithine) as Maintenance Therapy for High-Risk Neuroblastoma
LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved Iwilfin™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk... (Source: Drugs.com - New Drug Approvals)US WorldMeds Announces FDA Approval of IWILFIN™ (eflornithine) to Strengthen Fight Against Aggressive Childhood Cancer
LOUISVILLE, Ky.--(BUSINESS WIRE)--USWM, LLC (US WorldMeds) today announced that the U.S. Food and Drug Administration (FDA) has approved IWILFIN™ (eflornithine) 192 mg tablets, a groundbreaking oral maintenance therapy for high-risk neuroblastoma. IWILFIN is indicated to reduce the risk of relapse in adult and pediatric patients with high-risk neuroblastoma who have demonstrated at least a partial response to prior multiagent, multimodality therapy, including anti-GD2 immunotherapy. According tSpasticity Market Likely to Exhibit Substantial Growth by 2032, Predicts DelveInsight | Key Pharma Companies - Saol, Jazz, Supernus, Solstice Neurosciences, Ipsen, Merz, Motric Bio, SwanBio
The spasticity market is expected to grow due to factors like an increase in the patient pool and the expected entry of emerging therapies. LAS VEGAS, Nov. 23, 2023 /PRNewswire/ -- DelveInsight's Spasticity Market Insights report includes a comprehensive understanding of current treatment...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding US WorldMeds
Sign Up For FreeTo access detailed company insights
US WorldMeds is a specialty pharmaceutical company dedicated to developing, licensing and commercializing unique and significant specialty pharmaceuticals that address unmet medical needs or overcome limitations of existing products. Through sound science and targeted commercialization, the Kentucky-based company continually strives to identify spe... Read More
